Jacobio Pharmaceuticals Group Co., Ltd. is a biopharmaceutical company engaged in the research, development, and commercialization of innovative oncology treatments. The primary function of Jacobio Ph... Jacobio Pharmaceuticals Group Co., Ltd. is a biopharmaceutical company engaged in the research, development, and commercialization of innovative oncology treatments. The primary function of Jacobio Pharmaceuticals is to address unmet medical needs by developing targeted cancer therapies aimed at improving patient outcomes. Utilizing cutting-edge technologies and a robust scientific approach, the company focuses on novel drug discovery and pipeline advancement in the field of oncology. A notable feature of Jacobio is its emphasis on developing small molecule inhibitors, which are designed to hinder the biochemical processes that contribute to cancer progression. Jacobio Pharmaceuticals plays a significant role in the healthcare and pharmaceuticals sector, directly impacting both patient care and the broader medical research community. Headquartered in China, the company contributes to global advancements in cancer treatment, collaborating with various international research institutions and industry partners to bring innovative solutions to the market. Its efforts in oncology underscore its commitment to enhancing therapeutic options for patients battling cancer globally.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Jacobio Pharmaceuticals Group is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Jacobio Pharmaceuticals Group is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Jacobio Pharmaceuticals Group's data?

Start your 30-day free trial to request a data review for Jacobio Pharmaceuticals Group.

Start Free Trial

Legal Center Contact Us